TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225. January 4, 2002
TCL Archive In Brief Election Results Won’t Hurt Cancer Program, May Help; Coper To Stay If Carter Wants Him November 12, 1976